Immunohistochemical evidence showed that the increased expression of FN1 was mainly limited to the invasive front of thyroid cancer (38).CLU is a glycoprotein, which is involved in many physiological and pathological processes essential to carcinogenesis and tumor growth (39). This evidence concerns the gene FN1 and thyroid gland carcinoma.